EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Desensibilización a deferasirox en una paciente con hemocromatosis. Reporte de un caso

Nadia Karina Aguilar Hinojosa iD, Evelyn Itzamara Figueroa Saavedra iD

Revista Alergia México · 2023

DOI: 10.29262/ram.v70i3.1256 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Revista Alergia México, 2023. Verfasst von Nadia Karina Aguilar Hinojosa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Adscrita al servicio de Alergología. Hauptthemen laut MEDLINE: Deferasirox, Hemochromatosis, Iron Chelating Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deferasirox is an active iron chelator, used in the treatment of iron overload such as hemochromatosis. Up to 28% may present adverse reactions to said drug. A desensitization protocol for this drug may be useful when there are no other therapeutic options. Case report: A 52-year-old female with a diagnosis of hemochromatosis who began treatment with phlebotomy, poor response and tolerance, so it was decided to treat with deferasirox 500 mg daily, presenting symptoms of urticaria and angioedema on the third dose. Hospitalization was decided for a desensitization protocol with an initial dose of 0.6mg with a gradual increase in the dose, reaching a maintenance dose of 500 mg per day on the third day.

Conclusion

The rapid desensitization protocol for Deferasirox is useful when there is no response or therapeutic alternative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeferasiroxHemochromatosisIron Chelating AgentsFemaleHumansMiddle Aged

Stichwörter der Autor:innen

AllergyDeferasiroxDesensitizationHemochromatosisalergiadesensibilizaciónhemocromatosis

Substanzen

DeferasiroxIron Chelating Agents

Autor:innen und Institutionen

  • Adscrita al servicio de Alergología.
  • Instituto Mexicano del Seguro Social.

ORCID-Profile: Nadia Karina Aguilar Hinojosa, Evelyn Itzamara Figueroa Saavedra

Zitieren

APA

Aguilar Hinojosa, N. K., & Figueroa Saavedra, E. I. (2023). Desensibilización a deferasirox en una paciente con hemocromatosis. Reporte de un caso. Revista Alergia México. https://doi.org/10.29262/ram.v70i3.1256

Vancouver

Aguilar Hinojosa NK, Figueroa Saavedra EI. Desensibilización a deferasirox en una paciente con hemocromatosis. Reporte de un caso. Revista Alergia México. 2023. doi:10.29262/ram.v70i3.1256

BibTeX
@article{AguilarHinojosa2023,
  author = {Aguilar Hinojosa, Nadia Karina and Figueroa Saavedra, Evelyn Itzamara},
  title = {Desensibilización a deferasirox en una paciente con hemocromatosis. Reporte de un caso},
  journal = {Revista Alergia México},
  year = {2023},
  doi = {10.29262/ram.v70i3.1256}
}
Kostenlos starten →